Trial Profile
Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Oct 2016
Price :
$35
*
At a glance
- Drugs Rilonacept (Primary) ; Corticosteroid
- Indications Bursitis
- Focus Therapeutic Use
- 22 Oct 2016 New trial record